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In hereby congratulate Dr.Şeftalioğlu et al for their
work on lectins, on their report of binding of HPL-GC
to dog gastric mucin (1) emphasizing the applications
of protein and lipid glycosylation which once was considered as a topic whose appeal is restricted to a limited number of analytical biochemistry experts.
However, I would like to mention some points for
meticulous planning of their future research, as well
as drawing attention to variations of specificity in
commercial molecular conjugates, on occasion.
Lectins comprise a structurally very diverse class of
proteins characterized by their ability to bind carbohydrates with considerable specificity(2). An epitope,
though commonly refers to antigenic determinants
could be described in general protein-ligand interaction
terms, as an operational definition of a surface area
either directly responsible for, or intimately involved in
specific molecular interaction(3). Determination of
specificity of binding and revelation of binding sites or
motifs requires advanced chemical modification or mutational techniques supported by affinity testing which
could be done by employing labeling, as an example
(4).When talking of a specific epitope, description and
evidences should be at molecular level which must
have been already described by the supplier (Sigma,
UK) as the authors have mentioned as source of HPLGC.

Moreover as a control for specific recognition in
vivo the authors heve mentioned using "non-labeled"
lectin which obviously wouldn't result in any image.
Thus the selection of the internal experimental control
is improper for the purpose. Besides no(+) control has
been included in the experiment so that the reader
could depict the laid stain actually designates N. Acetyl
galactosamine (NAG) residues. This could be done by a
number of ways among which I could mention using
labeled MoAbs that have been shown to recognize
NAG residues(5), or O-glycosidase (eg. BoehringerMannheim) treatment of the sections to eliminate NAG
to distort the molecular integrity to end-up with a
change in staining properies which would be significant
as the folding properites of molecules could vary in
vivo(6).
Traditionally the discussion of an article should contain self-criticism of the obtained data in comparison
to relevant research rather than general information
from some research in the field. I would suggest, the
best reasonable conclusion to depict from the laid data
could be HPL-GC stains dog gastric mucosa better
than derivations about specific molecular recognition of
epitopes. I wish further success with the upcoming
studies.
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